For an orthopedic surgeon, the final note before signing off on a procedure is a point of no return. It is also, in the arcane logic of medical billing, the last chance to catch a coding error that could delay payment for months. A Palo Alto startup called Rette AI is betting that a layer of AI, trained specifically on orthopedic workflows, can spot those mistakes before the claim is ever submitted [Perplexity Sonar Pro Brief].
The company, founded in 2025, is building what it calls AI revenue-cycle-management software. Its initial focus is narrow: reviewing surgeons’ clinical notes, identifying gaps in documentation, suggesting accurate ICD-10 and CPT codes, and validating everything against the specific coverage policies of the patient’s insurer [Perplexity Sonar Pro Brief]. The goal is to prevent denials, not fight them after the fact. For small orthopedic practices and the specialty billing companies that serve them, that distinction could mean the difference between steady cash flow and a backlog of unpaid work.
The Kazakh Wedge Into U.S. Healthcare
Rette’s founding story is not a typical Silicon Valley narrative. Co-founders Sanzhar Myrzagalym and Kuanysh Idrissov first built a revenue cycle management company in their native Kazakhstan. According to an interview, that venture became the country’s most successful in its category, used by major hospitals across Central Asia [Stedi, November 2026]. That experience, they say, gave them a ground-level view of the universal friction points in medical billing, independent of any particular healthcare system.
They brought that perspective to Stanford’s d.school and later to StartX, the university’s startup accelerator, which accepted Rette into its Spring 2026 cohort [Rette AI, November 2026]. The team was rounded out by Zharaskhan Aman, a former Meta engineer and a two-time world finalist in the International Collegiate Programming Contest, who serves as CTO [Perplexity Sonar Pro Brief]. Their combined pitch was one of domain-specific precision: generic enterprise RCM systems are often too costly and complex for small specialty practices, leaving a gap that a focused AI tool could fill.
Inside the AI Checkpoint
Rette’s software is designed to integrate with a practice’s existing electronic health record system. As a surgeon completes a note, the AI reviews it for documentation integrity. It flags missing elements, suggests appropriate medical codes, and checks the proposed claim against a database of payer policies for potential mismatches [Perplexity Sonar Pro Brief]. The system also manages related workflows like prior authorizations, denials, appeals, and workers’ compensation cases in a unified queue.
A separate, publicly available product hints at the company’s broader ambition. Policy.rette.ai is an AI-powered search engine for healthcare payer policies. It is designed for billing teams to quickly look up coverage rules and modifier requirements, generating summaries from a vast corpus of policy documents [policy.rette.ai]. The company claims this tool has been running on “autopilot” and is already in use by billing teams across more than 20 U.S. cities [LinkedIn, Yelzhas Zhaksylyk, 2026].
The company’s early traction is bifurcated between its original market and its new target. As of September 2026, approximately 30 clinics were using the Kazakhstan version of the product [Ræm.kz, October 2026]. In the U.S., Rette reports design partnerships with orthopedic practices and billing companies that collectively manage over 500 practices across 35 states [StartX-related announcement]. These are early-stage validation partners, not necessarily paying customers, but they provide critical feedback loops for a system that must adapt to the dense thicket of U.S. payer rules.
Funding and Institutional Validation
Rette has taken an undisclosed amount of pre-seed financing from a group of investors including 500 Eurasia, JAS Ventures, and Astana Hub Ventures [Ræm.kz, October 2026]. While the round size is not public, the company’s progress through prestigious accelerators serves as a form of institutional validation. Beyond StartX, Rette was also selected for the June 2026 cohort of the Mayo Clinic Platform_Accelerate, one of 20 health-tech companies chosen for the program [Rette AI, November 2026].
This backing has supported a team that reportedly includes 17 employees and has achieved SOC 2 Type 1 compliance, an important baseline for handling protected health information [rocketreach.co] [LinkedIn, Gaziz Tazhenov, 2026]. The company’s leadership brings together a mix of AI engineering, product experience in global health tech, and that foundational experience in Central Asian healthcare.
| Role | Name | Key Background |
|---|---|---|
| CEO & Co-Founder | Sanzhar Myrzagalym | Stanford d.school; 9 years building AI at Microsoft [Perplexity Sonar Pro Brief]. |
| CPO & Co-Founder | Kuanysh Idrissov | Former head of product at YC-backed AlemHealth; co-founded leading Kazakh RCM company [Perplexity Sonar Pro Brief] [Stedi, November 2026]. |
| CTO & Co-Founder | Zharaskhan Aman | Former Meta engineer; two-time ICPC World Finalist [Perplexity Sonar Pro Brief]. |
The Uphill Climb in U.S. RCM
The ambition is clear, but the path is lined with formidable challenges. The U.S. revenue cycle management software market is crowded with entrenched incumbents like Epic, Cerner, and a host of specialized vendors. Rette’s bet is that its AI-first, orthopedic-specific approach offers a better economic model for smaller practices that are underserved by these giants. The risks, however, are multi-faceted.
- Clinical validation. An AI suggesting medical codes is operating in a high-stakes regulatory environment. While the tool is positioned as an assistant, its recommendations must be reliable. The company’s own policy search engine carries a disclaimer that users are solely responsible for verifying AI-generated content [policy.rette.ai]. Scaling trust will require demonstrated accuracy and, likely, published clinical validation studies.
- Sales motion. Penetrating U.S. medical practices, even small ones, is notoriously difficult. Sales cycles are long, and buyers are risk-averse with patient data and core financial operations. Rette’s partnerships with billing organizations, which serve many practices at once, could be a smarter channel, but it remains an unproven route to revenue at scale.
- Model specificity. Orthopedics is a smart beachhead, but it is also a vast field. A model trained on knee arthroscopy may not generalize to spinal fusion. Continuous expansion and tuning will be required, demanding more data and clinical input.
The company’s most plausible answer to these challenges lies in its accelerator pedigree and its pragmatic, partnership-driven approach. The Mayo Clinic connection provides access to clinical expertise, while the design partnerships with billing companies offer a potential distribution lever. The focus on a single specialty allows for deeper accuracy before attempting to broaden.
The Next Twelve Months
For Rette, the coming year will be about converting design partnerships into contracted customers and moving beyond the pre-seed stage. Key milestones to watch will be the announcement of a first U.S. paying client, a potential seed round to scale the commercial team, and any published data on the system’s impact on denial rates or revenue recovery.
The company is also likely to deepen its integration capabilities with major EHR platforms, a technical necessity for smooth adoption. How it navigates the balance between automated AI suggestions and necessary human oversight will be a central theme in its messaging to cautious healthcare providers.
For the orthopedic surgeons and billing staff who are Rette’s end-users, the promise is one of administrative relief. The standard of care today is a manual, error-prone process. A biller or coder must cross-reference dense operative notes with thousands of complex payer policies, a task that relies heavily on experience and is vulnerable to human fatigue. Denials are frequent, and the appeals process consumes further time and resources. Rette AI is proposing that much of this verification can be pre-emptively automated, shifting effort from reworking rejected claims to ensuring they are correct the first time. In a specialty where procedure volumes are high and reimbursement rates are under constant pressure, that efficiency could translate directly to financial stability for the practice. The company’s journey from Central Asia to the heart of the U.S. healthcare system is a test of whether that promise can cross borders and scale.
Sources
- [Perplexity Sonar Pro Brief] Company and product overview | https://rette.ai/about
- [Stedi, November 2026] Spotlight: Kuanysh Idrissov @ Rette AI | https://jobs.ashbyhq.com/notable
- [Ræm.kz, October 2026] Sanzhar Myrzagalym: Rette co-founder | https://jobs.ashbyhq.com/bjakcareer/da1e9f49-c0c3-408e-a685-89113dfabf21
- [Rette AI, November 2026] Rette joins Mayo Clinic Platform_Accelerate June 2026 cohort | https://jobs.ashbyhq.com/havocai/9f77117e-eb52-40e9-8c35-a7954514851f
- [Rette AI, November 2026] Rette was accepted into StartX, Stanford’s startup accelerator | https://jobs.ashbyhq.com/headway/3dd3085b-471c-4416-a782-9c9fccf7e32f
- [StartX-related announcement] LinkedIn post on policy.rette.ai traction and design partnerships
- [LinkedIn, Yelzhas Zhaksylyk, 2026] Post on policy.rette.ai autopilot operation
- [policy.rette.ai] AI-powered payer policy lookup tool | https://policy.rette.ai
- [rocketreach.co] Rette (Defect AI) employee count information
- [LinkedIn, Gaziz Tazhenov, 2026] Post on SOC 2 Type 1 compliance